← Back to headlines
Zhengye Biotechnology Regains Nasdaq Compliance Amidst Share Decline
Zhengye Biotechnology has regained compliance with Nasdaq's minimum bid price requirement, though its shares experienced a decline.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
